The Expression of Psoriasin (S100A7) and CD24 Is Linked and Related to the Differentiation of Mammary Epithelial Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Vegfors, Jenny ^a   Petersson, Stina ^a   Kovács, Anikó ^b   Polyak, Kornelia ^c   Enerbäck, Charlotta ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUCIN 1; PSORIASIN; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CELL DIFFERENTIATION; CELL HETEROGENEITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRADUCTAL CARCINOMA; PHENOTYPIC VARIATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANTIGENS, CD24; CELL DIFFERENTIATION; CELL LINE; EPITHELIAL CELLS; HUMANS; MAMMARY GLANDS, HUMAN; MUCIN-1; NF-KAPPA B; REACTIVE OXYGEN SPECIES; S100 PROTEINS; SIGNAL TRANSDUCTION;

EID: 84871649679     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053119     Document Type: Article

References (41)

1. Polyak K, (2007) Breast cancer: origins and evolution. J Clin Invest 117: 3155-3163.
2. Donato R, (1999) Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1450: 191-231.
3. Emberley ED, Murphy LC, Watson PH, (2004) S100A7 and the progression of breast cancer. Breast Cancer Res 6: 153-159.
4. Enerback C, Porter DA, Seth P, Sgroi D, Gaudet J, et al. (2002) Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 62: 43-47.
5. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, et al. (1999) Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155: 2057-2066.
6. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, et al. (2003) Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 63: 1954-1961.
7. Paruchuri V, Prasad A, McHugh K, Bhat HK, Polyak K, et al. (2008) S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation. PLoS One 3: e1741.
8. West NR, Watson PH, (2010) S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene 29: 2083-2092.
9. Shubbar E, Vegfors J, Carlstrom M, Petersson S, Enerback C, (2011) Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation. Breast Cancer Res Treat.
10. Borglum AD, Flint T, Madsen P, Celis JE, Kruse TA, (1995) Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21. Hum Genet 96: 592-596.
11. Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW, (1995) Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25: 638-643.
12. Martinsson H, Yhr M, Enerback C, (2005) Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation. Exp Dermatol 14: 161-168.
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
14. Lee JH, Kim SH, Lee ES, Kim YS, (2009) CD24 overexpression in cancer development and progression: A meta-analysis. Oncol Rep 22: 1149-1156.
15. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, et al. (2005) CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res 65: 10783-10793.
16. Kristiansen G, Sammar M, Altevogt P, (2004) Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35: 255-262.
17. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schluns K, et al. (2003) CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 9: 4906-4913.
18. Surowiak P, Materna V, Gyorffy B, Matkowski R, Wojnar A, et al. (2006) Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. Br J Cancer 95: 339-346.
19. Krop I, Marz A, Carlsson H, Li X, Bloushtain-Qimron N, et al. (2005) A putative role for psoriasin in breast tumor progression. Cancer Res 65: 11326-11334.
20. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, et al. (2003) Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253.
21. Carlsson H, Yhr M, Petersson S, Collins N, Polyak K, et al. (2005) Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants. Cancer Biol Ther 4: 998-1005.
22. Petersson S, Bylander A, Yhr M, Enerback C, (2007) S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells. BMC Cancer 7: 205.
23. Wolf R, Voscopoulos C, Winston J, Dharamsi A, Goldsmith P, et al. (2009) Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Cancer Lett 277: 101-107.
24. Wolf R, Howard OM, Dong HF, Voscopoulos C, Boeshans K, et al. (2008) Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 181: 1499-1506.
25. Carlsson H, Petersson S, Enerback C, (2005) Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. Int J Oncol 27: 1473-1481.
26. Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, et al. (1996) Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res 56: 4606-4609.
27. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, et al. (2003) Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 1: 362-375.
28. Martinsson H, Yhr M, Enerback C, (2004) Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation. Exp Dermatol in press.
29. Poumay Y, Pittelkow MR, (1995) Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J Invest Dermatol 104: 271-276.
30. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, et al. (1980) Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19: 245-254.
31. Watt FM, Jordan PW, O'Neill CH, (1988) Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc Natl Acad Sci U S A 85: 5576-5580.
32. Emberley ED, Niu Y, Curtis L, Troup S, Mandal SK, et al. (2005) The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer. Cancer Res 65: 5696-5702.
33. Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O, (2006) CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Pathol Res Pract 202: 569-576.
34. Fogel M, Friederichs J, Zeller Y, Husar M, Smirnov A, et al. (1999) CD24 is a marker for human breast carcinoma. Cancer Lett 143: 87-94.
35. Petersson S, Shubbar E, Yhr M, Kovacs A, Enerback C, (2011) Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells. Breast Cancer Res Treat 125: 13-25.
36. Celis JE, Cabezon T, Moreira JM, Gromov P, Gromova I, et al. (2009) Molecular characterization of apocrine carcinoma of the breast: Validation of an apocrine protein signature in a well-defined cohort. Mol Oncol.
37. Petersson S, Shubbar E, Yhr M, Kovacs A, Enerback C, (2010) Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells. Breast Cancer Res Treat.
38. Emberley ED, Alowami S, Snell L, Murphy LC, Watson PH, (2004) S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res 6: R308-315.
39. Rahn JJ, Dabbagh L, Pasdar M, Hugh JC, (2001) The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer 91: 1973-1982.
40. Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, et al. (1997) CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89: 3385-3395.
41. Cao X, Geradts J, Dewhirst MW, Lo HW, (2012) Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene 31: 104-115.